P440 Loss of response and dose escalation of infliximab and adalimumab in Ulcerative Colitis patients: A Systematic Review and Meta-analysis
Edo Savelkoul(Radboud University Nijmegen), Frank Hoentjen(Radboud University Nijmegen), Pepijn W. A. Thomas(Radboud University Nijmegen), Lauranne Derikx(Radboud University Nijmegen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Nathan den Broeder(Radboud University Nijmegen)
Cited by 2
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis
|New England Journal of Medicine|2021|269
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252
Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis
|Gastroenterology|2020|233
Reduction of Colitis by Prebiotics in HLA-B27 Transgenic Rats Is Associated with Microflora Changes and Immunomodulation
|Inflammatory Bowel Diseases|2005|215